RPL3 is a core component of the 60S ribosomal subunit involved in translation elongation. Two well-characterized antibodies include:
WB Validation: Both antibodies detect endogenous RPL3 at 46 kDa in multiple cell lines (HEK-293, RAW 264.7) .
IHC Performance: Strong cytoplasmic staining in human cancer tissues (liver, breast, lung) with antigen retrieval .
Subcellular Localization: Predominantly cytoplasmic in HepG2 cells via immunofluorescence .
RPS3 is a 27 kDa component of the 40S ribosomal subunit with roles in DNA repair and apoptosis.
Western Blot: Detects RPS3 at 27 kDa in HepG2, PC-12, and Neuro-2A lysates .
Immunofluorescence: Localizes to cytoplasmic ribosomes in Neuro-2A cells .
Clinical Relevance: Used to study ribosome biogenesis defects in cancer models .
Recent studies emphasize rigorous validation for ribosomal protein antibodies:
Cancer Biology: Used to quantify RPL3/RPS3 overexpression in hepatocellular carcinoma .
Neurological Studies: Neuro-2A cell models employ these antibodies to study ribosome stress .
Structural Biology: Supports cryo-EM studies of ribosomal complexes .
Batch Variability: 23% of commercial ribosomal antibodies show inter-lot inconsistency .
Epitope Mapping: Only 34% of antibodies targeting ribosomal proteins have mapped linear epitopes .
Phosphorylation Status: Most commercial antibodies do not distinguish phosphorylation states (e.g., RPS3 Ser6) .
Analytical framework:
Cross-platform validation: Compare RPPA results using clustered antibody-antigen maps to identify concordant/discordant signals (Fig. 1) .
Epitope mapping: Confirm antibody binding regions (e.g., UPF3B aa 300–350) to rule out isoform-specific artifacts .
Batch variability assessment: Replicate experiments with independent antibody lots to isolate technical vs. biological variability .
Integrated workflow:
Pair UPF3B WB/IP with RNA-seq to correlate nonsense-mediated decay (NMD) activity with mRNA stability .
Combine with phospho-specific antibodies (e.g., UPF1 phospho-sites) to study post-translational regulation of NMD .
Use machine learning to cluster UPF3B interaction partners identified via mass spectrometry .
Functional dissection:
Domain-specific mutagenesis: Delete UPF3B’s EJC-binding domain to isolate translation vs. NMD roles .
Ribo-seq: Compare ribosomal occupancy in UPF3B-knockout vs. wild-type cells under stress conditions .
Ternary complex assays: Use EMSA to test UPF3B’s interaction with UPF2 and RNA substrates in vitro .
Critical controls:
Data interpretation: